Credit Suisse is out with a research report on IBM IBM and is lowering estimates on the Armonk, N.Y.-based company. It has a Neutral rating and a $175 price target on shares.
In a note to clients, Credit Suisse writes, "We update our CY11/CY12 EPS estimates from $13.29/$14.77 to $13.23/$14.65 given building macro headwinds. The Public and Financial verticals, which represent 45% of sales, have exhibited weakness. Relative to other enterprise players, IBM has superior execution, services exposure and levers to protect its earnings, making it defensive near term."
Shares of IBM closed at $172.51 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsComputer HardwareCredit SuisseInformation Technology
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in